QuidelOrtho Corporation (QDEL)

Frontier Capital Management Co. LLC lifted its position in QuidelOrtho Corporation (NASDAQ: QDEL) by 37.6% in the second quarter, according to its most recent Form 13F filing with the Securities and E...

New York City-based Newtyn Management bought 994,332 shares of QuidelOrtho Corporation in the third quarter, increasing its position by an estimated $30.4 million. At quarter-end, the firm reported ho...

QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript...

Ameritas Investment Partners Inc. bought a new stake in QuidelOrtho Corporation (NASDAQ: QDEL) during the undefined quarter, according to the company in its most recent 13F filing with the Securities ...

SAN DIEGO , Nov. 24, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, announced today that members of its management team will part...

SAN DIEGO , Nov. 20, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 53 of its Science Bytes podcast, featuring Qian Ding, MD...

Bank of New York Mellon Corp increased its stake in shares of QuidelOrtho Corporation (NASDAQ: QDEL) by 3.0% during the undefined quarter, according to the company in its most recent disclosure with t...

QDEL tops Q3 estimates as Labs and Immunohematology units drive growth, while margins strengthen despite respiratory revenue declines....

QuidelOrtho Corporation ( QDEL ) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Juliet Cunningham - Vice President of Investor Relations Brian Blaser - President, CEO & Direct...

―  Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ― ― Successful completion of debt refinanci...